These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1138200)

  • 1. Radiation response of C3H fibrosarcoma enhanced in mice stimulated by Corynebacterium parvum.
    Suit HD; Sedlacek R; Wagner M; Orsi L
    Nature; 1975 Jun; 255(5508):493-4. PubMed ID: 1138200
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
    Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
    Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined radiotherapy and Corynebacterium parvum treatment of a murine fibrosarcoma.
    Collins AL; Song CW
    Radiology; 1977 Oct; 125(1):235-41. PubMed ID: 897175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy and Corynebacterium parvum in the treatment of murine tumors.
    Suit HD; Sedlacek RS; Silobrcic V; Linggood RM
    Cancer; 1976 Jun; 37(6):2573-9. PubMed ID: 949676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvum.
    Milas L; Gutterman JU; Basic I; Hunter N; Mavligit GM; Hersh EM; Withers HR
    Int J Cancer; 1974 Oct; 14(4):493-503. PubMed ID: 4459276
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with Corynebacterium parvum: reduced effect in irradiated recipients.
    Peters LJ; McBride WH; Mason KA; Hunter N; Basić I; Milas L
    J Natl Cancer Inst; 1977 Sep; 59(3):881-7. PubMed ID: 330869
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma.
    Stone HB; Peters LJ; Milas L
    J Natl Cancer Inst; 1979 Nov; 63(5):1229-35. PubMed ID: 291749
    [No Abstract]   [Full Text] [Related]  

  • 8. The mechanism of inhibition by Corynebacterium parvum of the growth of lung nodules from intravenously injected tumour cells.
    Bomford R; Olivotto M
    Int J Cancer; 1974 Aug; 14(2):226-35. PubMed ID: 4376512
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.
    Woodruff MF; McBride WH; Dunbar N
    Clin Exp Immunol; 1974 Jul; 17(3):509-18. PubMed ID: 4549691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for T lymphocytes in tumour inhibition and enhancement caused by systemic administration of Corynebacterium parvum.
    Peters LJ; McBride WH; Mason KA; Milas L
    J Reticuloendothel Soc; 1978 Jul; 24(1):9-18. PubMed ID: 308542
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy.
    Moore K; McBride WH
    Br J Cancer; 1983 Jun; 47(6):797-802. PubMed ID: 6860547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumour effects of Corynebacterium parvum in mice.
    Castro JE
    Eur J Cancer (1965); 1974 Feb; 10(2):121-7. PubMed ID: 4435007
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunomodulation of chemically induced fibrosarcoma by Corynebacterium parvum.
    Gupta N; Sehgal S; Aikat BK
    Indian J Med Res; 1980 Nov; 72():688-95. PubMed ID: 7203570
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of Corynebacterium parvum on cytotoxicity of regional and nonregional lymph node cells from animals with tumors present or removed.
    Fisher B; Wolmark N; Coyle J
    J Natl Cancer Inst; 1974 Dec; 53(6):1793-801. PubMed ID: 4471644
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined radiotherapy and Corynebacterium parvum treatment of rat tumors with different immunogenicity.
    Moroson H; Stowe S; Rotman M; Schechter M
    Int J Radiat Oncol Biol Phys; 1978; 4(7-8):649-55. PubMed ID: 711536
    [No Abstract]   [Full Text] [Related]  

  • 16. Lysozyme levels and macrophage content of tumor tissue in C3H mice bearing fibrosarcoma transplants treated by radiation and Corynebacterium parvum.
    Mendiondo O; Suit H; Fixler H
    Int J Radiat Oncol Biol Phys; 1978; 4(9-10):829-34. PubMed ID: 711553
    [No Abstract]   [Full Text] [Related]  

  • 17. Modification of radiation responses of murine tumors by misonidazole (Ro 07-0582), host immune capability, and Corynebacterium parvum.
    Stone HB; Milas L
    J Natl Cancer Inst; 1978 Apr; 60(4):887-93. PubMed ID: 633396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of transplanted methylcholanthrene induced fibrosarcomata and Corynebacterium parvum on the immune response of CBA and A-HeJ mice to thymus dependent and independent antigens.
    James K; Ghaffar A; Milne I
    Br J Cancer; 1974 Jan; 29(1):11-20. PubMed ID: 4820942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor antibodies and immunoglobulin class and subclass levels in Corynebacterium parvum-treated mice.
    James K; Willmott N; Milne I; McBride WH
    J Natl Cancer Inst; 1976 May; 56(5):1035-40. PubMed ID: 825650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of BCG and Corynebacterium Parvum on allograft survival after rabbit antimouse lymphocyte serum and donor bone marrow.
    Clark AW; Monaco AP
    Surg Forum; 1973; 24():340-3. PubMed ID: 4618660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.